Amgen bets on growth in China

Biotechnology company Amgen is investing U.S. $2.7 billion in the Chinese biotech firm Beigene. The all-cash deal values gives Amgen a 20% stake in BeiGene and going forward, BeiGene will commercialize some of Amgen’s cancer drugs which will be sold in China. The two...

Harvest announces May 2019 distributions for Big Pharma Split Corp

OAKVILLE, ONTARIO, May 21, 2019 – Harvest Portfolios Group Inc. (“Harvest”) declares the monthly cash distribution payable for Big Pharma Split Corp. of $0.1031 for each class A share (PRM:TSX) for the month ending May 31, 2019. The distribution is payable June 10,...

Harvest declares Big Pharma Split Corp. Distributions June 2018

OAKVILLE, ON, June 20, 2018 /CNW/ – Harvest Portfolios Group Inc. (“Harvest”) declares the monthly cash distribution payable for Big Pharma Split Corp. of $0.1031 for each class A share (PRM:TSX) for the month ending June 30, 2018. The distribution...